“…Measurements of extracellular pH using microelectrodes have shown regional variations in pH, with pH varying from 7.2 to 5.9 within the tumors (35). Other studies have shown that the oxygenation of the tumors can be improved by appropriate concomitant treatments with hyperbaric oxygen, carbogen, perflourochemical emulsions, allosteric effectors of hemoglobin, texaphyrins, or pentoxyfiline, and that these treatments provide the anticipated improvements in the response of the tumors to irradiation (2–4, 37–39). Past studies have also shown that hypoxic cell radiosensitizers such as misonidazole increase the radiosensitivity of the hypoxic tumor cells (3, 10, 27), and that drugs preferentially toxic to hypoxic cells, including mitomycin C, porfiromycin and KS119, as well as misonidazole, kill cells in the tumor cell populations that demonstrate hypoxic radioresistance (3, 9, 10, 21, 35, 40).…”